NervGen Pharma Corp (NGEN)
NCM · Common
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NGEN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
Business: NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. The Company’s mission is to transform the lives of individuals living with SCI by enabling the nervous system to repair itself. NervGen’s lead therapeutic candidate,

Company Contact

CEO
Adam Rogers
CFO
Keith Vendola
Headquarters
112-970 Burrard Street, Unit 1290, Vancouver, British Columbia, V6Z 2R4
Phone
778-731-1711
Investor Relations
Huitt Tracey · info@nervgen.com
SEC EDGAR Filings
View filings »